RxDoctor Payments Data

Ashley Allen, NP

Primary Care · Flowood, MSNPI 1295353290

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Lilly USA, LLC at 31.8% of the total. That places this record below the midpoint for primary care clinicians in MS, where the typical reported total is $380.

$391in general payments, 2019–2025

Across 10 payments — averaging $39.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$124
  • Mindray DS USA, Inc.$74
  • Sun Pharmaceutical Industries Inc.$63
  • Lundbeck LLC$48
  • Novartis$19
  • Exact Sciences$17
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$391100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$391 in reported general payments places this provider in the 50th percentile of 80 primary care providers in Mississippi.

See all primary care providers in Mississippi

Medicare billing

Part B allowed, 2024
$77,512
Medicare patients
366
Services billed
1,086

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$13,260
JardianceEmpagliflozin11$12,362
Mesalamine DrMesalamine11$2,116
Memantine Hcl31$1,579
Duloxetine Hcl44$913
Sertraline Hcl93$734
Mirtazapine14$646
Metoprolol Succinate27$436
Gabapentin34$431
Donepezil Hcl56$428
Pantoprazole Sodium28$403
Amlodipine Besylate55$356
Rosuvastatin Calcium33$356
Albuterol Sulfate HfaAlbuterol Sulfate16$354
Levothyroxine Sodium31$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$13,26013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 80 primary care providers in Mississippi.

Other primary care in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →